Drug Master Files for: ALCAFTADINE
✉ Email this page to a colleague
ALCAFTADINE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
20066 | A | II | 12/21/2006 | CILAG AG | ALCAFTADINE (R89674) DRUG SUBSTANCE |
27559 | I | II | 12/21/2013 | ENALTEC LABS PRIVATE LTD | ALCAFTADINE |
27982 | A | II | 2/18/2014 | CRYSTAL PHARMA SAU | ALCAFTADINE |
28277 | A | II | 5/8/2014 | NEULAND LABORATORIES LTD | ALCAFTADINE |
28932 | A | II | 2/4/2015 | MSN LABORATORIES PRIVATE LTD | ALCAFTADINE [ROUTE CODE FA] |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information